# Seroprevalence of Bordetella Pertussis Antibodies and Anti-pertussis Antibody Response After a Single Dose of Tdap in Pregnant Thai Women

> **NCT03498300** · EARLY_PHASE1 · COMPLETED · sponsor: **Mahidol University** · enrollment: 129 (actual)

## Conditions studied

- Pertussis
- Pregnancy Related

## Interventions

- **BIOLOGICAL:** Tdap vaccine

## Key facts

- **NCT ID:** NCT03498300
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-09
- **Primary completion:** 2019-04-13
- **Final completion:** 2019-04-13
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03498300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03498300, "Seroprevalence of Bordetella Pertussis Antibodies and Anti-pertussis Antibody Response After a Single Dose of Tdap in Pregnant Thai Women". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03498300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*